Dr. Ding Li is a professor at the School of Pharmaceutical Sciences at Sun Yat-sen University. He graduated from the Department of Chemistry at Peking University in 1989 and received his Ph.D. from the Department of Chemistry at the University of Minnesota in 1995. From 1995 to 2000, he worked as a research assistant and postdoctoral researcher at the Department of
Chemistry at Harvard University and Texas A&M University. From 2000 to 2009, he worked as an assistant professor and then an associate professor at the Department of Biochemistry at City University of Hong Kong. He joined Sun Yat-sen University in 2009. He has presided over more than ten scientific research projects, including four National Natural Science Foundation projects, two Hong Kong Research Grants Council research projects, and Guangdong Province and Guangzhou City research projects. Currently, he is mainly engaged in anti-cancer research, including the molecular mechanism by which small molecule compounds affect the expression of downstream oncogenes by regulating special DNA secondary structures in the gene promoter region and its binding protein.
Dr. Ding Li is a professor at the School of Pharmaceutical Sciences at Sun Yat-sen University. He graduated from the Department of Chemistry at Peking University in 1989 and received his Ph.D. from the Department of Chemistry at the University of Minnesota in 1995. From 1995 to 2000, he worked as a research assistant and postdoctoral researcher at the Department of
Chemistry at Harvard University and Texas A&M University. From 2000 to 2009, he worked as an assistant professor and then an associate professor at the Department of Biochemistry at City University of Hong Kong. He joined Sun Yat-sen University in 2009. He has presided over more than ten scientific research projects, including four National Natural Science Foundation projects, two Hong Kong Research Grants Council research projects, and Guangdong Province and Guangzhou City research projects. Currently, he is mainly engaged in anti-cancer research, including the molecular mechanism by which small molecule compounds affect the expression of downstream oncogenes by regulating special DNA secondary structures in the gene promoter region and its binding protein.